These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 30478106)
1. Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study). Saji N; Sakurai T; Ito K; Tomimoto H; Kitagawa K; Miwa K; Tanaka Y; Kozaki K; Kario K; Eto M; Suzuki K; Shimizu A; Niida S; Hirakawa A; Toba K; BMJ Open; 2018 Nov; 8(11):e021759. PubMed ID: 30478106 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP; Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380 [TBL] [Abstract][Full Text] [Related]
3. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
4. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K; Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811 [TBL] [Abstract][Full Text] [Related]
5. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study. Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K; Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095 [TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. Diener HC; Hart RG; Koudstaal PJ; Lane DA; Lip GYH J Am Coll Cardiol; 2019 Feb; 73(5):612-619. PubMed ID: 30732716 [TBL] [Abstract][Full Text] [Related]
7. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related]
8. [Atrial fibrillation as Risk Factor for Development of Cognitive Function Impairment and Dementia. Potential of Anticoagulant Therapy in Their Prevention]. Ostroumova OD; Cherniaeva MS; Golovina OV Kardiologiia; 2018 Sep; 58(9):76-88. PubMed ID: 30295203 [TBL] [Abstract][Full Text] [Related]
9. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M; Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study). Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y; J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691 [TBL] [Abstract][Full Text] [Related]
11. Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study. Rodríguez-Pascual C; Torres-Torres I; Gómez-Quintanilla A; Ferrero-Martínez AI; Sharma J; Guitián A; Basalo MC; Montero-Magan M; Vilches-Moraga A; Olcoz-Chiva MT; Paredes-Galán E; Rodríguez-Artalejo F J Am Med Dir Assoc; 2018 Nov; 19(11):936-941. PubMed ID: 29891182 [TBL] [Abstract][Full Text] [Related]
12. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation. Oertel LB; Fogerty AE J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry. Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM; Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study. Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB JAMA Cardiol; 2017 Aug; 2(8):872-881. PubMed ID: 28614582 [TBL] [Abstract][Full Text] [Related]
15. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases. Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837 [TBL] [Abstract][Full Text] [Related]
16. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation. Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M; Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222 [TBL] [Abstract][Full Text] [Related]
17. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048 [TBL] [Abstract][Full Text] [Related]
18. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Romero J; Cerrud-Rodriguez RC; Diaz JC; Michaud GF; Taveras J; Alviz I; Grupposo V; Cerna L; Avendano R; Kumar S; Kirchhof P; Natale A; Di Biase L Europace; 2018 Oct; 20(10):1612-1620. PubMed ID: 29982383 [TBL] [Abstract][Full Text] [Related]
19. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study. Giustozzi M; Vedovati MC; Verso M; Scrucca L; Conti S; Verdecchia P; Bogliari G; Pierpaoli L; Agnelli G; Becattini C Int J Cardiol; 2019 Apr; 281():56-61. PubMed ID: 30712846 [TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. Holbrook A; Dormuth C; Morrow R; Lee A; Troyan S; Li G; Pullenyegum E BMJ Open; 2016 Nov; 6(11):e013263. PubMed ID: 27884850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]